Researchers suggests patients with inflammatory bowel disease and primary sclerosing cholangitis should undergo annual colonoscopy once the diagnosis of the concomitant disease is made, according to a study published in Clinical Gastroenterology and Hepatology.
Researchers retrospectively reviewed data from 54 patients. Results showed patients with IBD and PSC have a risk of developing colonic neoplasms relatively soon after the two diseases are diagnosed. Therefore, researchers support previous colon cancer screening recommendations of yearly colonoscopies for that population of patients.
Read the abstract about PSC and IBD's role in colonic neoplasms.
Read other coverage about colonoscopies:
- Research Suggests High Endoscopy Completion Rates Tied to Fewer Missed Colorectal Cancers
- Study: Colonoscopy "Blind Spots" May Still Detect Cancer Risk
- Simply Education on Bowel Preparation Not Enough to Improve Prep Quality
Researchers retrospectively reviewed data from 54 patients. Results showed patients with IBD and PSC have a risk of developing colonic neoplasms relatively soon after the two diseases are diagnosed. Therefore, researchers support previous colon cancer screening recommendations of yearly colonoscopies for that population of patients.
Read the abstract about PSC and IBD's role in colonic neoplasms.
Read other coverage about colonoscopies:
- Research Suggests High Endoscopy Completion Rates Tied to Fewer Missed Colorectal Cancers
- Study: Colonoscopy "Blind Spots" May Still Detect Cancer Risk
- Simply Education on Bowel Preparation Not Enough to Improve Prep Quality